« Previous
Next »
Titles
- Part D plans generally include drugs commonly used by dual eligibles: 20191
- Patient Safety Organizations: hospital participation, value, and challenges1
- Pediatric HIV infection: drug product development for treatment1
- Pediatric and congenital heart surgery: 2014-2017 data1
- Pediatric information incorporated into human prescription drug and biological product labeling1
- Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products1
- Policy clarification for certain fluoroscopic equipment requirements: guidance for industry and Food and Drug Administration staff1
- Premarket tobacco product applications for electronic nicotine delivery systems1
- Preparation of food contact notifications for food contact substances in contact with infant formula and/or human milk1
- Prescription Drug User Fee Act waivers, reductions, and refunds for drug and biological products1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis1
- Primary care clinician participation in the CMS Quality Payment Program1
- Problems remain for ensuring that all high-risk Medicaid providers undergo criminal background checks1
- Process to request a review of FDA's decision not to issue certain export certificates for devices: guidance for industry and Food and Drug Administration staff1
- Provider shortages and limited availability of behavioral health services in New Mexico’s Medicaid managed care1